03/20/2024 4:23 PM | Aurinia Pharmaceuticals (Subject) ILJIN SNT Co., Ltd. (Filed by)
| Form SC 13D/A | |
03/07/2024 3:44 PM | Aurinia Pharmaceuticals (Issuer) Miller Joseph M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:46 PM | Aurinia Pharmaceuticals (Issuer) Greenleaf Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:41 PM | Aurinia Pharmaceuticals (Issuer) Robertson Stephen P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:42 PM | Aurinia Pharmaceuticals (Issuer) Habig Scott Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 3:43 PM | Aurinia Pharmaceuticals (Issuer) Donley Matthew Maxwell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:10 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
02/29/2024 3:11 PM | Aurinia Pharmaceuticals (Issuer) Knappertz Volker (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 3:31 PM | Aurinia Pharmaceuticals (Issuer) Donley Matthew Maxwell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 3:33 PM | Aurinia Pharmaceuticals (Issuer) Habig Scott Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 3:35 PM | Aurinia Pharmaceuticals (Issuer) Knappertz Volker (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 3:17 PM | Aurinia Pharmaceuticals (Issuer) Miller Joseph M (Reporting)
| Form 4/A | |
02/22/2024 3:19 PM | Aurinia Pharmaceuticals (Issuer) Robertson Stephen P. (Reporting)
| Form 4/A | |
02/15/2024 5:06 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 5:16 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 2:27 PM | ARMISTICE CAPITAL, LLC (Filed by) Aurinia Pharmaceuticals (Subject)
| Form SC 13G | |
02/12/2024 8:41 AM | Aurinia Pharmaceuticals (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/05/2024 5:02 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 5:01 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 5:05 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/22/2023 3:36 PM | Aurinia Pharmaceuticals (Issuer) Foster Robert T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/22/2023 3:31 PM | Aurinia Pharmaceuticals (Issuer) Foster Robert T (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/21/2023 3:06 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/21/2023 3:16 PM | Aurinia Pharmaceuticals (Issuer) Smith Karen L. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/21/2023 3:19 PM | Aurinia Pharmaceuticals (Issuer) Smith Karen L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 3:21 PM | Aurinia Pharmaceuticals (Issuer) Bailey Jeffrey Allen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/21/2023 3:25 PM | Aurinia Pharmaceuticals (Issuer) Bailey Jeffrey Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 5:03 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 5:07 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/06/2023 7:33 AM | Aurinia Pharmaceuticals (Subject) MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
07/03/2023 5:06 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/01/2023 1:01 PM | Aurinia Pharmaceuticals (Subject) MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/26/2023 3:39 PM | Aurinia Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/23/2023 4:14 PM | Aurinia Pharmaceuticals (Issuer) Leversage Jill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 4:16 PM | Aurinia Pharmaceuticals (Issuer) MacKay-Dunn R. Hector (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 4:16 PM | Aurinia Pharmaceuticals (Issuer) MILNE GEORGE M JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 4:17 PM | Aurinia Pharmaceuticals (Issuer) Billen Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 4:18 PM | Aurinia Pharmaceuticals (Issuer) Hagan Joseph P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 4:19 PM | Aurinia Pharmaceuticals (Issuer) Jayne David R.W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 4:22 PM | Aurinia Pharmaceuticals (Issuer) Balakrishnan Brinda (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 3:00 PM | Aurinia Pharmaceuticals (Subject) MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
05/11/2023 10:34 AM | Aurinia Pharmaceuticals (Subject) MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/10/2023 3:30 PM | Aurinia Pharmaceuticals (Subject) ILJIN SNT Co., Ltd. (Filed by)
| Form SC 13D/A | |
05/05/2023 10:17 AM | Aurinia Pharmaceuticals (Subject) MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/04/2023 5:06 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 5:10 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/03/2023 1:53 PM | Aurinia Pharmaceuticals (Subject) MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/02/2023 3:39 PM | Aurinia Pharmaceuticals (Filer)
| Form DEFA14A | |
04/26/2023 9:20 AM | Aurinia Pharmaceuticals (Subject) MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
04/05/2023 7:16 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2023 7:16 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |